Treatment of chronic thromboembolic pulmonary hypertension in a multidisciplinary team.
Anna SiennickaSzymona DarochaMarta BanaszkiewiczPiotr KędzierskiAnna DobosiewiczPiotr BłaszczakMałgorzata Peregud-PogorzelskaJarosław Damian KasprzakMichał TomaszewskiEwa MroczekBożena ZiębaDanuta KarasekKatarzyna Ptaszyńska-KopczyńskaKatarzyna Mizia-StecTatiana Mularek-KubzdelaAnna DoboszyńskaEwa LewickaMarcin RuchałaMaciej LewandowskiSylwia ŁukasikŁukasz ChrzanowskiDariusz ZielińskiAdam TorbickiMarcin KurzynaPublished in: Therapeutic advances in respiratory disease (2020)
The CTEPH team ensures that necessary diagnostic procedures are performed. A relatively low proportion of patients was assessed by the CTEPH team as operable and underwent surgery, which in survivors resulted in the best functional improvement. Although patients undergoing BPA(+MT) were older than patients treated with PEA, their survival was better than patients subjected to PEA or MT alone. The reviews of this paper are available via the supplemental material section.
Keyphrases
- end stage renal disease
- pulmonary hypertension
- ejection fraction
- patients undergoing
- newly diagnosed
- chronic kidney disease
- palliative care
- peritoneal dialysis
- quality improvement
- prognostic factors
- minimally invasive
- randomized controlled trial
- physical activity
- systematic review
- young adults
- pulmonary arterial hypertension
- coronary artery bypass
- coronary artery disease
- percutaneous coronary intervention
- patient reported
- community dwelling